The coronavirus disease 2019 (COVID-19) pandemic poses an enormous challenge to healthcare systems in affected communities. Older patients and those with pre-existing medical conditions have been identified as populations at risk of a severe disease course. It remains unclear at this point to what extent chronic liver diseases should be considered as risk factors, due…
JHEP Reports Template
Write in a clean editor, then format for JHEP Reports in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the JHEP Reports format
JHEP Reports is a peer-reviewed journal published by Elsevier, covering Liver Disease Diagnosis and Treatment, Liver Disease and Transplantation, Liver Diseases and Immunity.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, JHEP Reports 12 (2023) 45–58.
Formats any DOI in JHEP Reports style. No sign-up. |
| Publishes research in | Liver Disease Diagnosis and Treatment Liver Disease and Transplantation Liver Diseases and Immunity Hepatocellular Carcinoma Treatment and Prognosis Hepatitis B Virus Studies |
| ISSN | 2589-5559 |
| Citation impact (2-yr) | 4.31 |
| h-index | 74 |
| i10-index | 615 |
| Total citations | 27,674 |
| Article processing charge | $2,157 |
| Open access | Yes |
| Top institutions publishing here | Inserm |
| Journal website | www.journals.elsevier.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in JHEP Reports per year
Citation impact of JHEP Reports by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in JHEP Reports
The worldwide prevalence of non-alcoholic fatty liver disease (NAFLD) is estimated to have reached 25% or more in adults. NAFLD is prevalent in obese individuals, but may also affect non-obese insulin-resistant individuals. NAFLD is associated with a 2- to 3-fold increased risk of developing type 2 diabetes (T2D), which may be higher in patients with…
Lipids are a complex and diverse group of molecules with crucial roles in many physiological processes, as well as in the onset, progression, and maintenance of cancers. Fatty acids and cholesterol are the building blocks of lipids, orchestrating these crucial metabolic processes. In the liver, lipid alterations are prevalent as a cause and consequence of…
The diagnostic assessment of liver injury is an important step in the management of patients with chronic liver disease (CLD). Although liver biopsy is the reference standard for the assessment of necroinflammation and fibrosis, the inherent limitations of an invasive procedure, and need for repeat sampling, have led to the development of several non-invasive tests…
Non-alcoholic fatty liver disease (NAFLD) is the most prevalent liver disease worldwide, and a major cause of liver cirrhosis and hepatocellular carcinoma. NAFLD is intimately linked with other metabolic disorders characterized by insulin resistance. Metabolic diseases are driven by chronic inflammatory processes, in which macrophages perform essential roles. The polarization status of macrophages is itself…